Spectral takes EAA to Japan through Toray partnership:
This article was originally published in Clinica
Executive Summary
Spectral Diagnostics has expanded its partnership with Toray Medical by appointing it as exclusive distributor of the EAA test for sepsis risk. Tokyo-headquartered Toray will market and sell Spectral's EAA system as a stand-alone product and also in conjunction with its own Toraymyxin blood purification device. The two companies have been partners over the last three years to research the use of EAA together with Toraymyxin products. Toronto, Ontario-based Spectral said that the deal will also provide it with access to other Asian countries - Toray is established in China, Indonesia, Korea, Singapore and Thailand, as well as Japan. In addition to the Toray alliance, Spectral boosted its presence in the European market this year, by signing deals with Menarini and Estor to distribute the EAA system in Germany and Italy, respectively.